Welcome Medica Expo 13-16 NOV 2023

Zhejiang QL Biotech Team were presenting at MEDICA 2023 (Düsseldorf, Germany) .

As the company continues to develop, the R&D team continues to grow, the corresponding market response is very rapid, Zhejiang QL Biotech will launch some new products in the booth, such as drugs ETO, XYL, LSD, and many IVDR Products.

The Drug of Abuse series produced by Zhejiang QL Biotech are favored by customers, and our advantage is that we can flexibly customize cut off. It greatly meets the customization of customers and responds to the needs of the market at any time.

Customize cut off for Drug of Abuse As below

ETO 1000ng/ml    XYL1000ng/ml     LSD 20ng/ml       ETG 500ng/ml

AMP 300 ng/ml     BAR 100ng/ml     BZO 100ng/ml      COC 100 ng/ml   

MET 300ng/ml      MOP200 ng/ml    OXY 50ng/ml       PGB 1000ng/ml   

FYL   20ng/ml     THC 25 ng/ml      MTD 200ng/ml     TML 70ng/ml

Since Strep A Test has a large market inEurope European market, the company is applying for the professional using certificate of IVDR, and the certificate of self-testing is in the planning application.

The Strep A Rapid Test Device is a rapid chromatographic immunoassay for the qualitative  detection of Strep A antigen from throat swab specimens to aid in the diagnosis of Group A Streptococcal infection.

Streptococcus pyogenes is non‐motile gram‐positive cocci, which contains the Lancefield group A

to serious complications, including rheumatic fever and peritonsillar abscess.2 Traditional antigen that can cause serious infections such as pharyngitis, respiratory infection, impetigo, endocarditis, meningitis, puerperal sepsis, and arthritis.1 Left untreated, these infections can lead  identification procedures for Group A Streptococci infection involve the isolation and  identification of viable organisms using techniques that require 24 to 48 hours or longer.3,4 The Strep A Rapid Test Device is a rapid test to qualitatively detect the presence of Strep A antigen in throat swab specimens, providing results within 5 minutes. The test utilizes antibodies specific for whole cell Lancefield Group A Streptococcus to selectively detect Strep A antigen in a throat swab specimen.

After evaluating the data , the Sensitivity is more than 94.4% ，Specificity is more than  98.2% ，Accuracy is more than 97.4% .

Looking forward to 2024, Zhejiang QL Biotech will launch more new products to meet the needs of customers .

At last , let us meet Medica 2024 !